Hi dannybex......Thanks for bumping this thread up again
It would be good to get an update about the results of the AUTISM-MITOCHONDRIAL STUDY using L-carnitine supplementation [information posted below]
... Does anyone please have any further information/feedback about this study ?
AUTISM-MITOCHONDRIAL STUDY: PARTICIPANTS NEEDED
PRESS RELEASE CONTACT:
For Immediate Release
Genetic Consultants of Dallas
[Dir. Janet Kern, PhD, RN (Allen,
January 6, 2009 TX 75013) Tel.: 214-592-6600]
DALLAS, TX - ASD Centers, LLC has started a clinical study in the Dallas, Texas area.
This study is designed to examine how L-carnitine supplementation
affects behavior, cognition, muscle strength, and health/physical traits in those with a diagnosed autism spectrum disorder (ASD).
This study has already enrolled multiple participants and space is limited.
Study Background
L-carnitine is a naturally occurring amino acid required in energy metabolism. Carnitine is essential for the utilization of fatty acids to produce the energy needed to sustain cell function.
Carnitine deficiency is commonly found in children who have a diagnosis in the autism spectrum.
Mitochondrial dysfunction is also often found in those diagnosed with autism. And carnitine has been used to treat mitochondrial dysfunction.
Design of This Study
Participants: Thirty children 3-10 years of age, who have a diagnosis of autism, PDD-NOS, or other ASD or pervasive developmental disorder. Also, they cannot have had previous chelation therapy using DMSA or DMPS, and/or carnitine-based therapy,or methionine or lysine supplementation.
Study: Two-thirds of the children that participate in the study will receive treatment and one-third will receive a placebo. The study period is 3 months. Blood work and muscle strength testing will be done before and after treatment. There will be no costs to the participants.
For more information or if you would like to participate, please contact Dr. Janet Kern at: 214-592-6600 or
jkern@dfwair.net,
Janet Kern, PhD,
RN, Genetic Consultants of Dallas: 408 N. Allen Dr.,
Allen, Texas 75013-2500.
The Autism Research Institute (ARI) and CoMeD are supporting this study.
Your generous tax-free donations to ARI [1] or CoMeD [2] will help to fund additional research, similar to the present study, to establish appropriate curative therapies.
___________ _________ _________ _________ _________ ___
[1] To support the ongoing efforts of the ARI, with your tax-deductible contributions, please visit their website,
http://www.autism.com
[2] To support the ongoing efforts of CoMeD, Inc. with your tax-deductible contributions, please use the PayPal link on CoMeD's Internet website,
http://www.Mercury-freeDrugs.org.CoMeD,Inc. is a not-for-profit 501(c)(3) corporation that is actively engaged in legal, educational and scientific efforts to stop all use of mercury in medicine, and to ban the use of all mercury-containing medicines as well as to establish proven curative or supportive therapies for those who have been harmed.
Hopefully, most will find this Press Release to be
informative.
************ ********* ********* ********* ****
*The information provided in this email *
*and any attachment thereto is just that *
* -- information. *
* *
*It is not medical advice and it does not *
*require any specific action or actions. *
* *
*While the information is thought to be *
*accurate, no representation is made as *
*to the accuracy of the information posted*
*other than it is my best understanding of*
*the facts on the date that this email and*
*any attachments thereto are posted. *
* *
*Everyone should verify the accuracy of *
*the information provided for themselves *
*before acting on it. *
************ ********* ********* ********* ****
Respectfully,
Dr. King
http://www.dr-king.com